Your search returned 40 studies. (Get alerts for new studies):
- Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx - Stage III Squamous Cell Carcinoma of the Larynx - Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage III Squamous Cell Carcinoma of the Nasopharynx - Stage III Squamous Cell Carcinom
9 Locations available
- Dendritic Cell Vaccine for Head and Neck Cancer
Conditions: Squamous Cell Carcinoma of Head and Neck
1 Location available
- Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck - Basaloid Squamous Cell Carcinoma - Undifferentiated Carcinoma - Adenosquamous Cell Carcinoma
1 Location available
- Safety Study of Modified Vaccinia Virus to Cancer
Conditions: Melanoma - Breast Cancer - Head and Neck Squamous Cell Cancer - Liver Cancer - Colorectal Cancer - Pancreatic Adenocarcinoma
1 Location available
- A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
Conditions: Carcinoma, Squamous Cell
1 Location available
- Sexual Behavior in Head and Neck Cancer Patients
Conditions: Oropharyngeal Cancer - Head and Neck Cancer - Squamous Cell Carcinoma
1 Location available
- Four Doses of MAGE Vaccine for Patients With Squamous Cell Carcinoma of the Head and Neck
Conditions: Squamous Cell Carcinoma - Head and Neck Cancer
1 Location available
- Study of Sorafenib/Cetux in Head and Neck Cancer
Conditions: Squamous Cell Cancer
1 Location available
- Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)
Conditions: Head and Neck Cancer
2 Locations available
- Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma
Conditions: Head And Neck Cancer
1 Location available
- Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Car
Conditions: Head and Neck Cancer
5 Locations available
- Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response
Conditions: Head and Neck Cancer
1 Location available
- Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
Conditions: Squamous Cell Cancer - Head and Neck Cancer
5 Locations available
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Conditions: Refractory Head and Neck Cancer, Squamous Cell Carcinoma of the Skin, Carcinoma of the Breast, and Malignant Melanoma
4 Locations available
- Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck
Conditions: Head and Neck Cancer - Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - R
1 Location available
- MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Conditions: Advanced Nonhematological Malignancies - Non-Small Cell Lung Cancer - Small Cell Lung Cancer - Metastatic Breast Cancer - Head and Neck Squamous Cell Carcinoma - Gastroesophageal Adenocarcinoma
3 Locations available
- Phase II Study of RAD001 Head and Neck Cancer
Conditions: Squamous Cell Carcinoma of the Head and Neck
1 Location available
- A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Conditions: Ovarian Cancer - Non Small Cell Lung Cancer - Prostate Cancer - Colorectal Cancer - Gastric Cancer - Esophageal Cancer - Cancer of Head and Neck
23 Locations available
- Docetaxel And Cisplatin With or Without Erlotinib For Metastatic Or Recurrent Squamous Cell Carcinoma Of Head And Neck
Conditions: Head and Neck Cancer - Squamous Cell Carcinoma of the Head and Neck
1 Location available
- A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Conditions: Head and Neck Neoplasms
23 Locations available
- Randomized Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
Conditions: Head and Neck Cancer
1 Location available
- Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
Conditions: Carcinoma, Squamous Cell of the Head and Neck
25 Locations available
- Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract
Conditions: Upper Aerodigestive Tract Lesions - Neoplasms, Oropharyngeal - Oropharyngeal Cancer - Neoplasms, Hypopharyngeal - Hypopharyngeal Cancer - Head and Neck Neoplasms - UADT Neoplasms - Carcinoma, Squamous Cell - Papilloma
1 Location available
- Study of PX-866 and Docetaxel in Solid Tumors
Conditions: Non Small Cell Lung Cancer (NSCLC) - Squamous Cell Carcinoma of the Head and Neck (SCCHN)
28 Locations available
- Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer
Conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity - Recurrent Lymphoepithelioma of the Nasopharynx - Recurrent Lymphoepithelioma of the Oropharynx - Recurrent Mucoepidermoid Carcinoma of the Oral Cavity - Recurrent Squamous Cell Carcinoma of the Hypop
1 Location available
- Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma
Conditions: HEAD & NECK Cancer
1 Location available
- Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck
Conditions: Head and Neck Cancer
1 Location available
- Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- Trial of Induction Chemotherapy (ICT) Followed by Concurrent Chemoraditherapy (CR) With Monoclonal Antibody Cetuximab in Locally Advanced Head and Nec
Conditions: Head and Neck Squamous Cell Cancer
1 Location available
- TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- Stereotactic Body Radiotherapy for Head and Neck Tumors
Conditions: Squamous Cell Carcinoma of the Head and Neck - Nasopharyngeal Carcinoma - Salivary Gland Cancer - Head and Neck Sarcoma - Paraganglioma of Head and Neck - Chordoma of Head and Neck - Chondrosarcoma of Head and Neck - Angiofibroma of Head and Neck
1 Location available
- Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Conditions: Multiple Myeloma - Non-Hodgkin's Lymphoma - Glioblastoma Multiforme - Head and Neck Squamous Cell Cancer - Triple Negative Breast Cancer - Hormone Receptor-Positive Breast Cancer - Castration-Resistant Prostate Cancer - Ewing's Family of Sarcomas
2 Locations available
- Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
Conditions: Head and Neck Cancer - Oropharyngeal Cancer - Human Papillomavirus - Squamous Cell Cancer
1 Location available
- Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Head and Neck Cancer
1 Location available
- A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
Conditions: Colorectal Cancer - Squamous Cell Head and Neck Cancer - Non-small Cell Lung Cancer - Triple Negative Breast Cancer - Other Tumors With EGFR Dependence
2 Locations available
- Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer
Conditions: Head and Neck Squamous Cell Carcinoma
1 Location available
- Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- Intensity-Modulated Radiation Therapy, Pemetrexed Disodium, and Erlotinib Hydrochloride in Treating Patients With Recurrent or Second Primary Head and
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell Carcinoma of the Larynx - Recurren
2 Locations available
- Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer
Conditions: Carcinoma, Squamous Cell of Head and Neck
1 Location available
- Erlotinib Hydrochloride and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
Conditions: Squamous Cell Carcinoma of the Skin - Stage I Squamous Cell Carcinoma of the Hypopharynx - Stage I Squamous Cell Carcinoma of the Larynx - Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage I Squamous Cell Carcinoma of the Oropharynx - Sta
1 Location available
|